Despite the contradicting role of HDAC inhibitor in acute coronary artery disease, administration of tributyrin, VPA and TSA have reduced the scar size of MI, prevented cardiac dysfunction and repressed cardiac remodeling [155,156,157]. The gene discussed is HDAC9; the disease is myocardial infarction.